Novartis Publishes eBook of Meningococcal Disease Survivors - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Novartis Publishes eBook of Meningococcal Disease Survivors


PTSM: Pharmaceutical Technology Sourcing and Management
Volume 10, Issue 5

Novartis, in partnership with photographer Anne Geddes, the Confederation of Meningitis Organizations (CoMO), and charities around the world, have published an eBook featuring inspirational images of meningococcal disease survivors from around the world who have participated in the Protecting Our Tomorrows: Portraits of Meningococcal Disease campaign. This project aims to raise public awareness of meningococcal disease and the importance of vaccination. The eBook is available to download on iBooks.

"Through a series of what I believe are inspirational photographs of meningococcal disease survivors and families impacted by the disease, this project celebrates the survivors' triumphs and honors those who've tragically lost their lives," said Geddes. "Over my 30-year career, there is not one parent I have worked with who doesn't love their children, want to nurture their children and protect their children. Through these images, I hope parents feel empowered to understand the disease's impact and know the options available to them."

The eBook is the culmination of a worldwide project launched in 2013, aiming to raise awareness of meningococcal disease. Geddes meet with the 15 project participants from eight countries (Australia, Canada, Brazil, Germany, Ireland, Spain, UK, and US) to depict their resilience through their portraits. As global project ambassador, Geddes has also worked to promote awareness and encourage meningococcal disease education through meetings with journalists, patient advocacy organizations, and public officials.

Source: Novartis

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
Source: PTSM: Pharmaceutical Technology Sourcing and Management,
Click here